acetylcysteine has been researched along with Kidney Diseases in 264 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (2.27) | 18.7374 |
| 1990's | 7 (2.65) | 18.2507 |
| 2000's | 136 (51.52) | 29.6817 |
| 2010's | 101 (38.26) | 24.3611 |
| 2020's | 14 (5.30) | 2.80 |
| Authors | Studies |
|---|---|
| Aytuğ, H; Çoban, FK; Demirel, HH; İnce, S; İslam, İ | 1 |
| Bateman, DN; Briody, L; Cameron, S; Dhaun, N; Eddleston, M; Goddard, J; Gray, T; Hickson, K; Johnston, NR; Megson, IL; Morrison, EE; Norrie, J; Raja, K; Rees, JMB; Rushworth, G; Sandilands, EA; Thompson, AP; Treweeke, A; Uren, N; Webb, DJ; Wraight, J | 1 |
| Chen, CJ; Chen, WY; Chen, YF; Kuan, YH; Li, JR; Liao, SL; Ou, YC; Wu, CC; Yu, TM | 1 |
| Boydak, M; Dönmez, HH; Kaya, S; Yalçın, T | 1 |
| Bell, S; Guthrie, GD; Lambourg, E; Plumb, A; Traill, P; Walker, H; Zealley, I | 1 |
| Abdel-Daim, MM; Ahmed, OS; Hassanein, EHM; Mohamed, WR; Sayed, AM | 1 |
| Bhattacharya, I; Chakraborty, S; Mitra, RK | 1 |
| Chattipakorn, N; Kobroob, A; Palee, S; Peerapanyasut, W; Wongmekiat, O | 2 |
| Albulescu, D; Buga, AM; Burada, F; Calina, D; Ciurea, ME; Docea, AO; Iordache, AM; Mamoulakis, C; Mitrut, R; Rogoveanu, OC; Sosoi, S; Tsatsakis, A; Vasile, RC; Zlatian, O | 1 |
| Arent, Z; Dobrek, L; Kopanska, M; Nalik-Iwaniak, K; Thor, PJ | 1 |
| Gholamrezanezhad, A; Joyce, P; Salehi, S; Shin, H; Taghavifar, S | 1 |
| Liang, X; Lin, Z; Ling, Z; Liu, M; Xie, W | 1 |
| Honma, S; Sakai, M; Soma, I; Tani, I; Toriyabe, K; Yoshida, M | 1 |
| Antunes, AMM; Coelho, NR; Correia, MJ; Gonçalves-Dias, C; Monteiro, EC; Morello, J; Pereira, SA; Sequeira, CO; Soto, K; Vicente, JB | 1 |
| Abo-Youssef, AM; Hassan, MIA; Hemeida, RAM; Osman, AT; Sharkawi, SMZ | 1 |
| Abdel-Wahab, WM; Moussa, FI; Saad, NA | 1 |
| Chen, Z; Feng, Y; Huang, X; Li, L | 1 |
| Ababneh, MA; Al Demour, S; Alzoubi, KH; Hijjawi, TB; Rababa’h, AM | 1 |
| Açar, B; Akboğa, MK; Demirtaş, K; Ünal, S; Yayla, Ç; Yayla, KG | 1 |
| Chen, H; Chen, WM; Hua, Q; Li, DB; Li, HW; Li, J; Sun, XP; Zhu, WW | 1 |
| Chu, PY; Du, XJ; Fiedler, A; Giam, B; Horlock, D; Kaye, DM; Kiriazis, H; Kuruppu, S; Marques, FZ; Rajapakse, NW; Smith, AI | 1 |
| Fuentes-Calvo, I; López-Hernández, FJ; López-Novoa, JM; Martínez-Salgado, C; Morales, AI; Prieto, M; Prieto-García, L; Sancho-Martínez, SM | 1 |
| Gallagher, M; Palevsky, PM; Weisbord, SD | 1 |
| Adali, Y; Eroglu, HA; Kuzucu, M; Ozturk, O; Ustebay, S | 1 |
| Altintop, I; Balcioglu, E; Hanım Yay, A; Karakukcu, C; Ozturk, A; Soyer Sarica, Z; Tatli, M | 1 |
| Bai, XY; Cai, G; Chen, X; Cui, J; Hong, Q; Lin, S; Sun, X; Tang, L | 1 |
| Elshiekh, M; Kadkhodaee, M; Ranjbaran, M; Seifi, B | 1 |
| Rump, LC; Westenfeld, R | 1 |
| Jabr, FI | 1 |
| Alvarez-Gonzalez, A; Bouadma, L; Brochard, L; Chousterman, BG; Katsahian, S; Laissy, JP; Loric, S; Mekontso-Dessap, A; Moutereau, S; Rahmouni, A; Schortgen, F | 1 |
| Chung, BH; Doh, KC; Heo, SB; Jin, L; Kang, SH; Li, C; Lim, SW; Piao, SG; Yang, CW | 1 |
| Jones, AE; Kellum, J; Mitchell, AM; Nelson, T; O'Connor, J; Shapiro, NI; Tang, A; Traub, SJ | 1 |
| Hanly, L; Huang, SH; Koren, G; Regueira, O; Rieder, MJ; Shah, RK; Vasylyeva, TL | 1 |
| Chang, CF; Lin, CC | 1 |
| Ding, W; Gu, Y; Xu, C; Yang, L; Yang, M; Zhang, M | 1 |
| Christiansen, EH; Hansen, HS; Hansen, KN; Jensen, LO; Jensen, SE; Junker, A; Lassen, JF; Ravkilde, J; Thayssen, P; Thuesen, L; Veien, KT | 1 |
| Alkanat, M; Mungan, S; Orem, A; Ozkan, G; Ulusoy, S; Yucesan, FB; Yulug, E | 1 |
| Bittner, D; Bueche, CZ; Carare, RO; Garz, C; Härtig, W; Heinze, HJ; Kropf, S; Niklass, S; Reymann, KG; Schreiber, S; Stanaszek, L | 1 |
| Liu, W; Lv, S; Ren, W; Yang, K | 1 |
| Dervişoğlu, E; Doğan, NÖ; Erimşah, E; Kama, A; Pekdemir, M; Yaka, E; Yılmaz, S | 1 |
| Akbari, H; Dorri, F; Hosseinzadeh, F; Iranirad, L; Miryounesi, M; Nazeri, A; Pazoki, S; Vafaeimanesh, J; Vahedian, M; Yeganehkhah, MR | 1 |
| Aydın, A; Börcek, P; Karakan, T; Koca, G; Öğüş, E; Sunay, M | 1 |
| Gao, YW; Tang, L; Wang, ZC; Wei, RB; Xing, Y; Yang, Y; Zheng, XY | 1 |
| Izcovich, A; Rada, G | 1 |
| Annabi, A; El-Bini Dhouib, I; El-Fazaa, S; El-Golli, N; Gharbi, N; Jrad, A; Lasram, MM | 1 |
| Farsaei, S; Karimzadeh, I; Khalili, H; Sagheb, MM | 1 |
| Cai, GY; Chen, XM; Huang, MJ; Li, P; Li, QP; Wang, N; Wang, R; Wei, RB; Yang, X | 1 |
| Ai, ZS; Hu, DY; Kang, X; Li, CB; Peng, A | 1 |
| Caristo, ME; Ciavarella, LP; Citterio, F; Copponi, G; Crea, F; Cusumano, G; Giubilato, S; Liuzzo, G; Manchi, M; Romagnoli, J; Severino, A; Stigliano, E; Zannoni, GF | 1 |
| Solomon, R | 2 |
| Habib, M; Hammad, A; Hillis, A | 1 |
| Aboagye, J; Bass, EB; Choi, MJ; Eng, J; Hutfless, S; Sherrod, C; Suarez-Cuervo, C; Subramaniam, RM; Turban, S; Wilson, RF; Zhang, A | 1 |
| Helal, MA | 1 |
| Atmaca, HT; Bayir, Y; Canayakin, D; Halici, Z; Keles, MS; Kilic Baygutalp, N; Kocak Ozgeris, FB; Sezen Karaoglan, E | 1 |
| Cao, F; Chen, Y; Qian, G; Su, H | 1 |
| Gan, XX; Lu, LM; Miao, NJ; Shen, Y; Xu, D; Xu, JL; Xue, H; Zhang, W; Zhou, L | 1 |
| Irwin, MG; Lee, EY; Wong, GT | 1 |
| Chen, B; Chen, W; Han, J; He, T; Hu, J; Huang, N; Huang, Y; Jiang, Y; Liao, Y; Mei, H; Yan, T; Zhang, Q | 1 |
| Ahmad, SF; Al-Harbi, MM; Al-Harbi, NO; Alotaibi, MR; AlSaad, AM; Ansari, MA; Nadeem, A | 1 |
| Yano, T | 1 |
| Bashir, I; DeLago, A; El-Hajjar, M; Khan, M; Min, J; Torosoff, M | 1 |
| Fought, J; Rehman, T; Solomon, R | 1 |
| Danner, RL; Gonzales, DA; Kern, SJ; Natanson, C; Star, RA | 1 |
| Trivedi, H | 1 |
| Barlis, P; Ferrante, G; Locca, D | 1 |
| Berwanger, O | 1 |
| Massicotte, A | 1 |
| Asano, R; Hamada, H; Kamiyama, N; Ogawa, R; Ohno, T; Umemura, J; Yoshida, H | 1 |
| Fernandes, C; French, JK; Hallani, H; Jepson, N; Juergens, CP; Leung, DY; Lo, S; Nguyen-Do, P; Winter, JP | 1 |
| Kang, JH; Kim, BJ; Kim, BS; Kim, H; Lee, KB; Lee, MH; Sung, KC | 1 |
| Rudnick, MR; Sterling, KA; Tehrani, T | 1 |
| Aublet-Cuvelier, B; Cellarier, E; Decalf, V; Deteix, P; Heng, AE; Marcaggi, X; Motreff, P; Souweine, B | 1 |
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydłowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Chen, N; Hanly, L; Koren, G; Rieder, M | 1 |
| Cronin, RE | 1 |
| Bell, SP; Chen, Z; Dauerman, HL; LeWinter, MM; Meyer, M; Selby, DE; Singla, DK | 1 |
| Fischell, TA | 1 |
| Coppola, JT; Doucet, S; Katholi, RE; Mody, KR; Sharma, SK; Solomon, R; Staniloae, CS | 1 |
| Abaci, O; Baskurt, M; Dogan, GM; Ersanli, M; Gurmen, T; Kilickesmez, K; Okcun, B; Ozkan, AA | 1 |
| Honkanen, E; Kokki, H; Laisalmi-Kokki, M; Lindgren, L; Pesonen, E; Pitkänen, M; Teppo, AM; Valta, P | 1 |
| Barone, MT; Danna, P; Ferrario, F; Genderini, A; Heidemperger, M; Landoni, G; Piccaluga, E; Scorza, D; Trezzi, M | 1 |
| Amini, M; Amirbaigloo, A; Esfahani, F; Masoudkabir, F; Salarifar, M | 1 |
| Abdelrahman, AM; Al husseni, IS; Al Salam, S; Ali, BH; AlMahruqi, AS; Mansour, MA | 1 |
| Bartorelli, AL; Daram, S; Marenzi, G; Szabo, A; Trivedi, H | 1 |
| Butnaru, A; Korenfeld, R; Lifschitz, M; Shavit, L; Slotki, I | 1 |
| Cao, J; Chen, D; Liu, Z; Wang, L | 1 |
| Cohan, RH; Ellis, JH | 1 |
| Rajapakse, S; Wijewickrama, ES | 1 |
| Jang, HS; Kim, J; Park, KM | 1 |
| Cass, A; Gallagher, M; Huxley, R; Jardine, M; Ninomiya, T; Patel, A; Perkovic, V; Sadigh, G; Vasheghani-Farahani, A; Zoungas, S | 1 |
| Dehpour, AR; Javidnia, K; Kheradpezhouh, E; Miri, R; Monabati, A; Noorafshan, A; Panjehshahin, MR | 1 |
| Block, CA; Brown, JR; Malenka, DJ; O'Connor, GT; Schoolwerth, AC; Thompson, CA | 1 |
| Dauerman, HL | 1 |
| Aiyagari, R; Bove, EL; Charpie, JR; Devaney, EJ; Gelehrter, S; Gurney, JG; Hirsch, JC; Ohye, RG | 1 |
| Araujo, CR; De la Cruz Rodríguez, LC; Posleman, SE; Rey, MR | 1 |
| Caixeta, A; Mehran, R | 2 |
| Blasco, M; Carbonell, N; Jordá, A; Miguel, A; Sanjuán, R | 1 |
| Cha, RH; Joo, KW; Kim, DK; Kim, S; Kim, SM; Kim, YS; Lee, JP; Lim, CS; Oh, KH | 1 |
| Liu, J; Wang, L; Wang, Z | 1 |
| Argirov, M; Merkle, M; Sauter, M; Wörnle, M | 1 |
| Bosotti, L; Castini, D; Lombardi, F; Lucreziotti, S; Salerno Uriarte, D; Sponzilli, C; Verzoni, A | 1 |
| Bianchi, R; Calabrò, P; Calabrò, R; Capozzi, G; Cappelli Bigazzi, M; Caprile, M; Cuomo, S; Gigantino, G; Limongelli, G; Palmieri, R; Sordelli, C | 1 |
| Kagan, A; Sheikh-Hamad, D | 1 |
| Furutani, Y; Hayano, T; Kinbara, T; Matsuzaki, M; Moritani, K; Ohtani, N | 1 |
| Barrios, V; Echarri, R; Escobar, C | 1 |
| Barbosa, PR; Cardoso, MR; Dal-Pizzol, F; Daufenbach, JF; Gonçalves, CL; Machado, RA; Rezin, GT; Roza, CA; Scaini, G; Schuck, PF; Streck, EL | 1 |
| Bürgelová, M; Cervenka, L; Kopkan, L; Kramer, HJ; Peregrin, JH; Sochman, J | 1 |
| Bouchier-Hayes, DJ; Lee, MJ; Moloney, MA; O'Donnell, DH | 1 |
| Boyle, JR; Gillard, JH; Norden, AG; Sadat, U; Walsh, SR | 1 |
| Chong, E; Liang, S; Poh, KK; Soon, CY; Tan, HC | 1 |
| Derici, U; Ebinc, FA; Elmas, C; Goktas, G; Gulbahar, O; Oguzulgen, IK; Ozyilmaz, E; Sindel, S | 1 |
| Sochman, J | 1 |
| Nadella, R; Szabo, A; Trivedi, H | 1 |
| Burns, KE; Martin, C; Priestap, F | 1 |
| Alihanoglu, Y; Aygul, MU; Ayhan, S; Dogdu, O; Erkorkmaz, U; Gunebakmaz, O; Kalay, N; Karabag, T; Kaya, MG; Kayrak, M; Koc, F; Ozdemir, K; Sonmez, O; Vatankulu, MA | 1 |
| Hayashi, H; Katoh, H; Machii, M; Nobuhara, M; Ohtani, H; Saitoh, T; Saotome, M; Satoh, H; Tanaka, T; Urushida, T | 1 |
| Hamatani, H; Hiromura, K; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakairi, T; Takahashi, S; Takeuchi, S; Tomioka, M | 1 |
| Benck, U; Birck, R; Braun, C; Göttmann, U; Hoeger, S; Krämer, BK; Krzossok, S; Schnuelle, P; Weiss, E | 1 |
| Fujita, M; Hirai, T; Miki, K; Suzuki, N; Suzuki, Y; Tanaka, A; Tanaka, T; Yasuda, N | 1 |
| Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G | 1 |
| Allaqaband, S; Bajwa, T; Hafiz, AM; Jan, MF; Mori, N; Shaikh, F; Wallach, J | 1 |
| Collins, TJ; Grant, AG; Grise, MA; Jaffery, Z; Jenkins, JS; McMullan, PW; Patel, RA; Ramee, SR; Reilly, JP; Thornton, SN; Verma, A; White, CJ | 1 |
| Adams, V; Blase, P; Desch, S; Droppa, M; Eitel, I; Fuernau, G; Schuler, G; Thiele, H | 1 |
| Nahl, D; Rundback, JH; Yoo, V | 1 |
| Barreto, DV; Barreto, FC; Eloot, S; Glorieux, G; Liabeuf, S; Massy, Z; Schepers, E; Vanholder, R | 1 |
| Alioglu, E; Duman, C; Ercan, E; Kirilmaz, B; Saygi, S; Tengiz, I; Turk, U; Tuzun, N; Yildiz, S | 1 |
| Akpek, M; Calapkorur, B; Günebakmaz, O; Inanc, MT; Karadag, Z; Kasapkara, A; Kaya, MG; Koc, F; Oguzhan, A; Yarlioglues, M | 1 |
| Akdeniz, C; Aslanger, E; Cizgici, Y; Oflaz, H; Polat, N; Uslu, B | 1 |
| Mehran, R; Sergie, Z | 1 |
| Inci, MF; Inci, R; Salk, I; Solak, O; Vurdem, UE | 1 |
| Bilasy, ME; Ismail, HM; Maklady, FA; Oraby, MA | 1 |
| Baraban, OV; Borisenok, OA; Bushma, MI; Zimatkin, SM | 1 |
| Chung, BH; Doh, KC; Hyoung, BJ; Lim, SW; Piao, SG; Yang, CW | 1 |
| Chen, YC; Hsu, TF; Huang, MK; Huang, MS; Kao, WF; Yen, DH; Yu, SH | 1 |
| Huang, K; Liang, R; Luo, Y; Shen, XL; Wang, Y; Xu, W; Zhang, Y; Zheng, J | 1 |
| Aurelio, A; Basile, E; Buffon, A; Burzotta, F; Crea, F; De Caterina, AR; Leone, AM; Lioy, E; Mazzari, MA; Mongiardo, R; Niccoli, G; Panocchia, N; Porto, I; Rebuzzi, AG; Romagnoli, E; Sciahbasi, A; Trani, C | 1 |
| Grace, PA; Healy, DA; Moloney, MC; O'Sullivan, S; Walsh, SR | 1 |
| Kwok, CS; Loke, YK; Pang, CL; Yeong, JK | 1 |
| Elfarra, AA; Irving, RM; Pinkerton, ME | 1 |
| Aloisi, C; Arena, A; Baldari, S; Buemi, F; Buemi, M; Giardina, C; Lacquaniti, A; Lupica, R; Murè, G; Visalli, C | 1 |
| Cao, L; Cheng, L; Fu, Q; Jin, W; Li, Z; Sun, Z | 1 |
| Tepel, M; Zidek, W | 3 |
| Allaqaband, S; Bajwa, TK; Gupta, A; Malik, AM; Shalev, Y; Tumuluri, R; Volkert, P | 1 |
| Brinker, JA | 1 |
| Lepor, NE | 2 |
| Goldfarb, M; Heyman, SN; Karmeli, F; Rosen, S; Shina, A | 1 |
| Biddle, WP; Cichowski, E; Hilleman, DE; Mooss, AN; Oldemeyer, JB; Wurdeman, RL | 1 |
| DiDomenico, RJ; Eyrich, HM | 1 |
| Huxtable, L; Khera, GS; Raney, CR | 1 |
| Brokering, KL; Theobald, JC; Walker, PD | 1 |
| Durham, JH; Fishbane, S; Marzo, K; Rudnick, M | 1 |
| Gami, AS; Garovic, VD | 1 |
| Billinger, M; Hess, OM; Meier, B | 1 |
| Balestrieri, P; Bonizzoni, E; Briguori, C; Colombo, A; Focaccio, A; Golia, B; Lepore, S; Librera, M; Manganelli, F; Paolo Elia, P; Ricciardelli, B; Riviezzo, G; Scarpato, P; Violante, A | 1 |
| Agrawal, M; Denu-Ciocca, C; Finn, WF; Franceschini, N; Kshirsagar, AV; Magnus Ohman, E; Mottl, A; Poole, C; Shoham, D; Tudor, G | 1 |
| Hladunewich, M; Ma, IW | 1 |
| Morcos, SK | 1 |
| Lee, H; Manns, B; Pannu, N; Tonelli, M | 1 |
| Andrade, L; Barros de Toledo, JF; Drager, LF; Laurindo, FR; Machado César, LA; Seguro, AC | 1 |
| Addala, S; Boura, J; Grines, C; Isayenko, Y; Kahn, J; O'Neill, W; Ochoa, A; Pellizzon, G; Rempinski, D | 1 |
| Banas, B; Fischereder, M; Hoffmann, U; Krämer, BK | 1 |
| Axelson, C; Nicol, P | 1 |
| Airoldi, F; Balestrieri, P; Briguori, C; Castelli, A; Colombo, A; Focaccio, A; Golia, B; Lepore, S; Librera, M; Paolo Elia, P; Ricciardelli, B; Riviezzo, G; Scarpato, P; Violante, A | 1 |
| Fremes, SE; Guru, V | 1 |
| Al Shamari, A; Buller, CE; Fox, RS; Humphries, KH; Levin, A; Pate, GE; Shalansky, S; Sutander, A; Webb, JG; Williams, T | 1 |
| Atchison, D; Barolet, A; Daly, P; Dzavik, V; Ing, D; Lewycky, P; McLaughlin, PR; Miner, SE; Mitchell, J; Nguyen-Ho, P; Richardson, R; Ross, J; Schwartz, L; Seidelin, P | 1 |
| Bagshaw, SM; Ghali, WA | 1 |
| Bates, ER; Hofer, TP; Humes, HD; Moscucci, M; Nallamothu, BK; Saint, S; Shojania, KG | 1 |
| Hsu, CY; Shah, SJ | 1 |
| Cirit, M; Toprak, O | 1 |
| Azmus, AD; Bulcão, L; Duro, K; Frey, M; Gottschall, C; Lima, C; Manica, A; Manica, J | 1 |
| Bonventre, JV; Lin, J | 1 |
| Burroughs, M; Grossman, PD; Guthmann, RA | 1 |
| Bent, S; Ix, J; Liu, R; Moore, DH; Nair, D | 1 |
| Araújo, A; Bezerra, HG; Bodanese, LC; Brito, FS; Brizolara, A; Caramori, AP; Caramori, P; Gomes, VO; Lasevitch, R; Nery, P; Poli de Figueredo, CE; Röedel, AP | 1 |
| Levin, A; Pate, GE; Shalansky, SJ; Webb, JG | 1 |
| Cieciorka, M; Ineck, BA; Kline, ME; Ng, TM; Nissen, LR; O'Leary, EL; Porter, LL; Puumala, SE; Rigmaiden, RS; Shurmur, SW; Silver, M | 1 |
| Barghouth, G; Schaad, N | 1 |
| de Fijter, C; Schultz, MJ; Smit, W; Tonino, S; van den Berk, G | 1 |
| Aydogdu, S; Diker, E; Eraslan, H; Gulel, O; Keles, T; Ulusoy, V | 1 |
| Culley, CM; Krenzelok, EP | 1 |
| Humphries, KH; Levin, A; Pate, GE; Shalansky, SJ; Vu, T; Webb, JG | 1 |
| Allada, CS; Dias, L; Keogh, AM; Kotlyar, E; Muller, D; Sharp, J; Thavapalachandran, S | 1 |
| Azadpour, M; Hennekens, CH; Mercado, C; Zagler, A | 1 |
| Aitio, ML | 1 |
| Abbate, A; Agostoni, P; Biondi-Zoccai, GG; Burzotta, F; Crea, F; Lotrionte, M; Remigi, E; Romagnoli, E; Testa, L; Valgimigli, M | 1 |
| Erdogan, H; Fadillioglu, E; Irmak, MK; Uçar, M; Yagmurca, M | 1 |
| Barrett, BJ; Parfrey, PS | 1 |
| Aspelin, P; Lameire, N; Tepel, M | 1 |
| Pannu, N; Tonelli, M | 1 |
| Briguori, C; Marenzi, G | 1 |
| Tepel, M | 1 |
| Abbott, KC; Coyle, LC; Jeschke, RE; Rodriguez, A; Simon-Lee, A; Taylor, AJ | 1 |
| Toprak, O | 1 |
| Eckel, F; Fritsch, R; Hamar, P; Heemann, U; Hennico, R; Hennig, M; Huber, W; Meining, A; Rosenbrock, H; Saur, D; Schenk, C; Schmelz, R; Schmid, RM; Sennefelder, A; Wacker, A; Weiss, W | 1 |
| Assanelli, E; Bartorelli, AL; Campodonico, J; De Metrio, M; Fabbiocchi, F; Galli, S; Grazi, M; Lauri, G; Marana, I; Marenzi, G; Montorsi, P; Veglia, F | 1 |
| Blasco, M; Bodí, V; Carbonell, N; García-Ramón, R; Insa, L; Miguel, A; Núñez, J; Pérez-Sancho, E; Sanchis, J; Sanjuán, R | 1 |
| Bulbuloglu, E; Cetinkaya, A; Kantarceken, B; Kurutas, EB | 1 |
| Abraham, T; Hameed, S; Padmaja, NP; Pillai, RK; Ramesh, N; Vijayaraghavan, G | 1 |
| Baas, MC; Schultz, MJ; Smit, W; Stamkot, GA; van der Sluijs, HP | 1 |
| Aguiar-Souto, P; Domínguez, JF; Valero-González, S | 1 |
| Ritz, E | 1 |
| Cafri, C; Wolak, A; Zahger, D | 1 |
| Balderramo, DC | 1 |
| Dwyer, TM; Hughson, MD; Jordan, S; Manning, RD; Rose, RA; Tian, N | 1 |
| Amberg, A; Dekant, W; Hard, GC; Mally, A | 1 |
| Jia, H; Knowlton, G; Nykamp, D; Pang, D; Schmidt, P | 1 |
| Brar, C; Vaitkus, PT | 1 |
| Airoldi, F; Bonizzoni, E; Briguori, C; Carlino, M; Colombo, A; Cosgrave, J; D'Andrea, D; Focaccio, A; Michev, I; Montorfano, M; Morici, N; Ricciardelli, B | 1 |
| Celik, S; Erdogan, S; Gorur, S; Hakverdi, S; Ocak, S | 1 |
| Fung, JW; Szeto, CC; Yu, CM | 1 |
| Barrett, B; Benko, A; Capusten, B; Fraser-Hill, M; Magner, P; Myers, A; Owen, RJ | 1 |
| Mehran, R | 1 |
| Bartels, H; Beck, FX; Fraek, ML; Holzapfel, K; Neuhofer, W | 1 |
| Aleksa, K; Chen, N; Koren, G; Rieder, M; Woodland, C | 2 |
| Coca, SG; Perazella, MA | 1 |
| Akdeniz, B; Akyildiz, IZ; Aslan, O; Badak, O; Baris, N; Guneri, S; Ozcan, EE; Senaslan, O | 1 |
| Enomoto, S; Hoshino, A; Kawahito, H; Kurata, H; Nakahara, Y; Nakamura, T | 1 |
| Gallo, K; Mainra, R; Moist, L | 1 |
| DeRose, G; Elliot, J; Forbes, TL; Harris, KA; Kribs, SW; Lawlor, DK; Lovell, MB; Moist, L | 1 |
| Erley, C | 1 |
| Barshteyn, N; Elfarra, AA | 1 |
| Dickey, DT; Doolittle, ND; Kraemer, DF; Muldoon, LL; Neuwelt, EA; Peterson, DR | 1 |
| Dangas, G; Mehran, R; Pucelikova, T | 1 |
| Banks, S; Danner, RL; Gonzales, DA; Kern, SJ; Natanson, C; Norsworthy, KJ; Sieving, PC; Star, RA | 1 |
| Schultz, MJ | 1 |
| Aktoz, T; Atakan, IH; Aydoğdu, N; Inci, O; Kaplan, M; Ozpuyan, F; Seren, G; Tokuç, B | 1 |
| Andreotti, F; Coluzzi, G; Santucci, E | 1 |
| Bagshaw, SM; Bellomo, R; Dragun, D; Haase, M; Haase-Fielitz, A; Morgera, S; Ratnaike, S; Reade, MC | 1 |
| Locatelli, F | 1 |
| Armijo-Medina, H; Bubalo, J; Doolittle, ND; Kaufman, JA; Muldoon, LL; Neuwelt, EA; Peterson, DR; Stenstrom, DA; Watnick, S | 1 |
| Burigo, M; Constantino, L; Dal-Pizzol, F; Di-Pietro, PB; Dias, ML; Machado, RA; Scaini, G; Streck, EL | 1 |
| Al Otaibi, T; Hussain, N; Nampoory, MR | 1 |
| Bouzas-Mosquera, A; Recio-Mayoral, A | 1 |
| Andrade, L; Danilovic, A; Libório, AB; Sanches, TR; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
| Aleksandrowicz, E; Larczynski, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Detrenis, S; Meschi, M; Savazzi, G | 1 |
| Bugan, B; Celik, T; Isik, E; Iyisoy, A; Yuksel, UC | 1 |
| Anderson, T; Duelge, J; Hansen, RM; Holoye, PY; Ritch, PS | 1 |
| Goulding, R; Meredith, TJ | 1 |
| Galova, I; Karaivanova, M; Konstantinov, S; Topashka-Ancheva, M; Zoneva, G | 1 |
| Furukawa, F; Hasegawa, R; Inoue, T; Kurokawa, Y; Nishikawa, A; Sai-Kato, K; Toyokuni, S; Uchida, K; Umemura, T | 1 |
| Ishmael, J; Lock, EA | 2 |
| Anders, MW; Baggs, RB; Iyer, RA; Uttamsingh, V | 1 |
| Shaikh, ZA; Tang, W; Vu, T; Zaman, K | 1 |
| Harris, DC; Rangan, GK; Tay, YC; Wang, Y | 1 |
| Funaki, B | 1 |
| Damián, FJ; Jaramillo, F; Llamas, J; Loarca-Piña, MG; Martínez, A; Martínez, C; Ortíz, R; Quezada, T; Reyes, JL; Rodríguez, ML; Valdivia, AG; Yamamoto, L | 1 |
| Anestis, DK; Ball, JG; Brown, PI; Henderson, TT; Hong, SK; Rankin, GO; Valentovic, MA | 1 |
| Adam, RD; Critchley, JA; Illingworth, RN; Prescott, LF; Proudfoot, AT; Stewart, MJ | 1 |
| Möller-Hartmann, W; Siegers, CP | 1 |
| Commandeur, JN; Stijntjes, GJ; Vermeulen, NP; Wijngaard, J | 1 |
| Brakenhoff, JP; Commandeur, JN; De Kanter, FJ; Vermeulen, NP | 1 |
| Mertens, JJ; Spenkelink, B; Temmink, JH; van Bladeren, PJ; van Doorn, WJ; Weijnen, JG | 1 |
70 review(s) available for acetylcysteine and Kidney Diseases
| Article | Year |
|---|---|
Systematic review and meta-analysis of prophylaxis use with intravenous contrast exposure to prevent contrast-induced nephropathy.
Topics: Acetylcysteine; Adult; Contrast Media; Humans; Kidney Diseases; Renal Insufficiency; Sodium Bicarbonate | 2022 |
The role of inflammation in cadmium nephrotoxicity: NF-κB comes into view.
Topics: Acetylcysteine; Cadmium; Cytochalasin D; Cytokines; Humans; Inflammation; Kidney Diseases; NF-kappa B; Polysaccharides; Sildenafil Citrate; Telmisartan | 2022 |
Current comments on contrast media administration in patients with renal insufficiency.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Humans; Kidney Diseases; Renal Insufficiency; Sodium Bicarbonate | 2021 |
Latest Clinical Evidence About Effect of Acetylcysteine on Preventing Contrast-Induced Nephropathy in Patients Undergoing Angiography: A Meta-Analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Creatinine; Humans; Kidney; Kidney Diseases | 2021 |
N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Biomarkers; Chi-Square Distribution; Contrast Media; Creatinine; Drug Therapy, Combination; Humans; Kidney Diseases; Odds Ratio; Protective Factors; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2018 |
Current concepts of contrast-induced nephropathy: a brief review.
Topics: Acetylcysteine; Contrast Media; Coronary Angiography; Hemofiltration; Humans; Kidney Diseases; Renal Dialysis | 2013 |
Should acetylcysteine be used to prevent contrast induced nephropathy?
Topics: Acetylcysteine; Contrast Media; Humans; Iodine; Kidney Diseases; Randomized Controlled Trials as Topic | 2015 |
N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.
Topics: Acetylcysteine; Contrast Media; Diabetic Nephropathies; Humans; Kidney Diseases; Randomized Controlled Trials as Topic; Renal Insufficiency | 2015 |
Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Contrast Media; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Odds Ratio; Sodium Bicarbonate; Sodium Chloride; United States | 2016 |
Contrast induced nephropathy in vascular surgery.
Topics: Acetylcysteine; Contrast Media; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning; Kidney Diseases; Renal Replacement Therapy; Vascular Surgical Procedures | 2016 |
[Etiology of iodinated radiocontrast nephrotoxicity and its attenuation by beraprost].
Topics: Acetylcysteine; Animals; Apoptosis; Ceramides; Contrast Media; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; Epoprostenol; Fumonisins; Humans; Iodine Compounds; Kidney Diseases; Kidney Tubules; Mice; Phosphorylation; Proto-Oncogene Proteins c-bcl-2 | 2008 |
Contrast medium-induced nephropathy: strategies for prevention.
Topics: Acetylcysteine; Administration, Oral; Contrast Media; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Kidney Diseases; Pharmacists; Risk Factors; Sodium Bicarbonate | 2008 |
Clinical significance and preventive strategies for contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Contrast Media; Fluid Therapy; Hemofiltration; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Renal Dialysis; Sodium Bicarbonate; Theophylline | 2008 |
Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention.
Topics: Acetaldehyde; Acetylcysteine; Age Factors; Antineoplastic Agents, Alkylating; Antioxidants; Child; Humans; Ifosfamide; Kidney Diseases; Oxidative Stress; Risk Factors | 2009 |
Contrast-induced nephropathy: pathogenesis and prevention.
Topics: Acetylcysteine; Contrast Media; Health Planning Guidelines; Humans; Isotonic Solutions; Kidney Diseases; Randomized Controlled Trials as Topic; Risk Factors; Sodium Bicarbonate; Sodium Chloride | 2010 |
High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Aged; Contrast Media; Female; Humans; Kidney Diseases; Male | 2009 |
Prevention of contrast-induced nephropathy: an overview.
Topics: Acetylcysteine; Contrast Media; Creatinine; Fluid Therapy; Hemofiltration; Humans; Kidney Diseases; Kidney Function Tests; Premedication | 2009 |
Non-dialytic management of sepsis-induced acute kidney injury.
Topics: Acetylcysteine; Acute Disease; Contrast Media; Dopamine; Evidence-Based Medicine; Fluid Therapy; Humans; Hypoglycemic Agents; Insulin; Kidney Diseases; Osmotic Pressure; Perfusion; Risk Assessment; Risk Factors; Sepsis; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Contrast Media; Heart Failure; Humans; Injections, Intravenous; Kidney Diseases; Mortality; Renal Dialysis; Risk; Sodium Bicarbonate | 2009 |
Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Biomarkers; Contrast Media; Creatinine; Drug Therapy, Combination; Evidence-Based Medicine; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Sodium Bicarbonate; Treatment Outcome | 2009 |
Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.
Topics: Acetylcysteine; Acute Disease; Animals; Combined Modality Therapy; Contrast Media; Cytoprotection; Evidence-Based Medicine; Fluid Therapy; Hemofiltration; Humans; Kidney Diseases; Practice Guidelines as Topic; Renal Dialysis; Risk Assessment; Risk Factors; Sodium Bicarbonate; Treatment Outcome | 2010 |
Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Disease; Angioplasty, Balloon, Coronary; Contrast Media; Dopamine; Drug Administration Routes; Evidence-Based Medicine; Fenoldopam; Fluid Therapy; Humans; Kidney Diseases; Patient Selection; Practice Guidelines as Topic; Protective Agents; Radiography, Interventional; Risk Assessment; Risk Factors; Sodium Bicarbonate; Treatment Outcome | 2010 |
Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Randomized Controlled Trials as Topic; Sodium Bicarbonate; Sodium Chloride | 2010 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Antioxidants; Contrast Media; Evidence-Based Medicine; Fenoldopam; Fluid Therapy; Humans; Kidney Diseases; Risk Assessment; Risk Factors; Treatment Outcome; Vasodilator Agents | 2011 |
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Creatinine; Humans; Kidney Diseases; Randomized Controlled Trials as Topic | 2013 |
Measures used to treat contrast-induced nephropathy: overview of reviews.
Topics: Acetylcysteine; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Prevalence; Risk Assessment; Sodium Bicarbonate; Theophylline; Treatment Outcome | 2013 |
Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.
Topics: Acetylcysteine; Administration, Intravenous; Contrast Media; Humans; Kidney Diseases; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Acetylcysteine and contrast media nephropathy.
Topics: Acetylcysteine; Animals; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Radiography | 2002 |
A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Contrast Media; Diabetes Complications; Dogs; Dopamine Agonists; Evaluation Studies as Topic; Fenoldopam; Fluid Therapy; Free Radical Scavengers; Humans; Ischemia; Kidney Diseases; Kidney Tubules; Models, Animal | 2003 |
A review of pharmacologic interventions to prevent contrast-induced nephropathy.
Topics: Acetylcysteine; Adenosine; Calcium Channel Blockers; Contrast Media; Creatinine; Fenoldopam; Furosemide; Hemodynamics; Humans; Kidney Diseases; Mannitol; Prostaglandins | 2003 |
Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.
Topics: Acetylcysteine; Contrast Media; Dopamine Agonists; Fenoldopam; Free Radical Scavengers; Humans; Ischemia; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic | 2003 |
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Clinical Trials as Topic; Contrast Media; Humans; Ischemia; Kidney; Kidney Diseases; Kidney Tubules; Radiography | 2004 |
Contrast nephropathy after coronary angiography.
Topics: Acetylcysteine; Contrast Media; Coronary Angiography; Free Radical Scavengers; Humans; Iatrogenic Disease; Isotonic Solutions; Kidney Diseases; Osmolar Concentration; Risk Factors; Sodium Chloride | 2004 |
N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.
Topics: Acetylcysteine; Contrast Media; Controlled Clinical Trials as Topic; Humans; Kidney Diseases; Prospective Studies; Radiopharmaceuticals | 2004 |
Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?
Topics: Acetylcysteine; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Renal Insufficiency | 2004 |
Prevention of contrast media nephrotoxicity--the story so far.
Topics: Acetylcysteine; Alprostadil; Atrial Natriuretic Factor; Contrast Media; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Fenoldopam; Hemofiltration; Humans; Kidney Diseases; Renal Dialysis; Risk Factors; Vasodilator Agents | 2004 |
Systematic review of the impact of N-acetylcysteine on contrast nephropathy.
Topics: Acetylcysteine; Contrast Media; Humans; Injections, Intravenous; Kidney Diseases; Randomized Controlled Trials as Topic; Sample Size | 2004 |
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.
Topics: Acetylcysteine; Clinical Trials as Topic; Contrast Media; Humans; Kidney Diseases; Radiopharmaceuticals | 2004 |
The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Randomized Controlled Trials as Topic | 2004 |
N-Acetylcysteine in nephrology; contrast nephropathy and beyond.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Contrast Media; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic | 2004 |
Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis.
Topics: Acetylcysteine; Angiography; Contrast Media; Humans; Kidney Diseases | 2004 |
Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Radiography; Randomized Controlled Trials as Topic | 2004 |
Prevention of radiocontrast nephropathy.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases | 2005 |
Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients?
Topics: Acetylcysteine; Contrast Media; Hemofiltration; Humans; Kidney Diseases; Osmolar Concentration; Risk Factors; Sodium Bicarbonate; Sodium Chloride | 2005 |
N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.
Topics: Acetylcysteine; Contrast Media; Creatinine; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Randomized Controlled Trials as Topic | 2005 |
[The use of acetylcysteine for preventing contrast-induced nephropathy].
Topics: Acetylcysteine; Antioxidants; Contrast Media; Humans; Kidney Diseases; Risk Factors | 2005 |
Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
Topics: Acetylcysteine; Contrast Media; Critical Care; Fenoldopam; Free Radical Scavengers; Hemofiltration; Humans; Kidney Diseases; Sodium Bicarbonate; Theophylline; Treatment Outcome; Vasodilator Agents | 2005 |
A clinical and pharmacoeconomic justification for intravenous acetylcysteine: a US perspective.
Topics: Acetaminophen; Acetylcysteine; Administration, Oral; Adult; Contrast Media; Humans; Injections, Intravenous; Kidney Diseases | 2005 |
N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?
Topics: Acetylcysteine; Administration, Oral; Animals; Contrast Media; Humans; Injections, Intravenous; Kidney Diseases | 2005 |
N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic | 2006 |
N-acetylcysteine -- passe-partout or much ado about nothing?
Topics: Acetylcysteine; Anti-HIV Agents; Antioxidants; Cardiovascular Diseases; Drug Therapy, Combination; Expectorants; HIV Infections; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Neoplasms; Oxidative Stress; Reactive Oxygen Species | 2006 |
Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.
Topics: Acetylcysteine; Contrast Media; Guideline Adherence; Humans; Journalism, Medical; Kidney Diseases; Meta-Analysis as Topic; Quality Control; Randomized Controlled Trials as Topic; Research Support as Topic; Review Literature as Topic | 2006 |
Clinical practice. Preventing nephropathy induced by contrast medium.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Diabetes Mellitus, Type 2; Fluid Therapy; Humans; Hypertension; Kidney Diseases; Male; Practice Guidelines as Topic; Risk Factors | 2006 |
Contrast-induced nephropathy: a clinical and evidence-based approach.
Topics: Acetylcysteine; Acute Disease; Animals; Contrast Media; Humans; Incidence; Kidney Diseases | 2006 |
Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.
Topics: Acetylcysteine; Ascorbic Acid; Contrast Media; Evidence-Based Medicine; Fenoldopam; Humans; Kidney Diseases; Osmolar Concentration; Risk Factors; Theophylline | 2006 |
N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unit.
Topics: Acetylcysteine; Contrast Media; Free Radical Scavengers; Humans; Intensive Care Units; Kidney Diseases | 2006 |
N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Meta-Analysis as Topic; Publication Bias | 2007 |
Contrast media nephropathy--how to diagnose and how to prevent?
Topics: Acetylcysteine; Antioxidants; Contrast Media; Humans; Injections, Intra-Arterial; Kidney Diseases; Primary Prevention; Renal Dialysis; Risk Factors; Vasodilator Agents | 2007 |
Contrast-induced nephropathy remains a serious complication of PCI.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progression; Fenoldopam; Humans; Incidence; Kidney Diseases; Prognosis; Risk Factors; Sodium Bicarbonate | 2007 |
Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: clinical pharmacokinetic considerations.
Topics: Acetylcysteine; Humans; Ifosfamide; Kidney Diseases | 2007 |
[Iodinated contrast agent-induced nephropathy].
Topics: Acetylcysteine; Acute Kidney Injury; Age Factors; Angiography; Clinical Trials as Topic; Contrast Media; Diabetes Complications; Free Radical Scavengers; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Renal Replacement Therapy; Risk Factors; Theophylline; Tomography, X-Ray Computed; Vasodilator Agents | 2007 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Fenoldopam; Free Radical Scavengers; Heart Failure; Humans; Iatrogenic Disease; Kidney Diseases; Kidney Transplantation; Multivariate Analysis; Osmolar Concentration; Phosphodiesterase Inhibitors; Prognosis; Renal Dialysis; Risk Factors; Theophylline | 2008 |
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.
Topics: Acetylcysteine; Aged; Cluster Analysis; Contrast Media; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Publication Bias; Randomized Controlled Trials as Topic; Regression Analysis; Renal Dialysis; Risk Factors; Sensitivity and Specificity | 2007 |
N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
Topics: Acetylcysteine; Clinical Trials, Phase III as Topic; Contrast Media; Humans; Kidney Diseases | 2008 |
Contrast media nephropathy: in depth review.
Topics: Acetylcysteine; Calcium Channel Blockers; Contrast Media; Diabetic Nephropathies; Dopamine; Endothelin Receptor Antagonists; Humans; Kidney Diseases; Mannitol; Renal Insufficiency; Risk Factors | 2008 |
[Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines].
Topics: Acetylcysteine; Acute Kidney Injury; Age Factors; Aged; Contrast Media; Creatinine; Critical Care; Diabetes Complications; Glomerular Filtration Rate; Hemofiltration; Humans; Italy; Kidney Diseases; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors | 2008 |
Paracetamol.
Topics: Acetaminophen; Acetylcysteine; Adult; Animals; Chemical and Drug Induced Liver Injury; Child; Cysteamine; Dextropropoxyphene; Humans; Infant; Kidney Diseases; Methionine | 1980 |
Acetylcysteine for radiocontrast nephropathy.
Topics: Acetylcysteine; Animals; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubules; Reactive Oxygen Species | 2001 |
60 trial(s) available for acetylcysteine and Kidney Diseases
| Article | Year |
|---|---|
Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast-Induced Nephropathy: A Failure of Academic Clinical Science.
Topics: Acetylcysteine; Antioxidants; Contrast Media; Creatinine; Cross-Over Studies; Humans; Kidney Diseases; Renal Insufficiency, Chronic; Treatment Outcome | 2022 |
N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography.
Topics: Acetylcysteine; Adult; Contrast Media; Crystalloid Solutions; Double-Blind Method; Female; Humans; Infusions, Intravenous; Isotonic Solutions; Kidney Diseases; Male; Sodium Bicarbonate; Sodium Chloride; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Topics: Acetylcysteine; Aged; Contrast Media; Creatinine; Drug Therapy, Combination; Electrocardiography; Female; Humans; Incidence; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Sodium Bicarbonate; Treatment Outcome | 2014 |
Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention.
Topics: Acetylcysteine; Administration, Oral; Contrast Media; Female; Humans; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Sodium Bicarbonate; Sodium Chloride | 2014 |
Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Administration Schedule; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Iohexol; Kidney Diseases; Male; Middle Aged; Prospective Studies; Protective Agents; Sodium Bicarbonate; Sodium Chloride; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Comparison between three supportive treatments for prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography.
Topics: Acetylcysteine; Aged; Antioxidants; Biomarkers; Blood Urea Nitrogen; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Humans; Hydrogen-Ion Concentration; Iohexol; Iran; Kidney Diseases; Male; Middle Aged; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Time Factors; Treatment Outcome | 2014 |
A double-blinded, placebo-controlled, multicenter clinical trial of N-acetylcysteine for preventing amphotericin B-induced nephrotoxicity.
Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cystatin C; Double-Blind Method; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Kidney Diseases; Kidney Function Tests; Male; Membrane Glycoproteins; Middle Aged; Receptors, Virus; Young Adult | 2015 |
N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Contrast Media; Coronary Angiography; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2016 |
N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients.
Topics: Acetylcysteine; Aged; Antioxidants; Biomarkers; Chronic Disease; Contrast Media; Creatinine; Cystatin C; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Radiography; Severity of Illness Index; Time Factors | 2008 |
Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Female; Humans; Injections, Intravenous; Iohexol; Kidney; Kidney Diseases; Male; Sodium Chloride; Triiodobenzoic Acids | 2009 |
Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Cystatin C; Female; Free Radical Scavengers; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Regression Analysis | 2010 |
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iopamidol; Kidney Diseases; Male; Prospective Studies; Sodium Bicarbonate; Treatment Outcome; Triiodobenzoic Acids | 2008 |
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
Topics: Acetylcysteine; Adult; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Biomarkers; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Fibrosis; Humans; Kidney Diseases; Kidney Tubules; Male; Proteinuria; Treatment Outcome | 2008 |
Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Placebos; Research Design | 2009 |
N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Drug Therapy, Combination; Female; Humans; Incidence; Kidney Diseases; Male; Sodium Chloride; Theophylline | 2009 |
Potentially detrimental effects of N-acetylcysteine on renal function in knee arthroplasty.
Topics: Acetylcysteine; Acetylglucosaminidase; Aged; Alpha-Globulins; Arthroplasty, Replacement, Knee; Creatinine; Cystatin C; Double-Blind Method; Female; Free Radical Scavengers; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Injections, Intravenous; Isoenzymes; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Middle Aged; Prospective Studies | 2009 |
Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Topics: Acetylcysteine; Aged; Contrast Media; Female; Free Radical Scavengers; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Osmolar Concentration; Prospective Studies | 2009 |
N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Placebos; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors | 2009 |
Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Contrast Media; Creatine; Dehydration; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Prospective Studies; Regression Analysis; Risk Assessment; Sodium Bicarbonate; Sodium Chloride; Statistics as Topic | 2009 |
Effects of N-acetylcysteine on renal dysfunction in neonates undergoing the arterial switch operation.
Topics: Acetylcysteine; Antioxidants; Cardiac Surgical Procedures; Double-Blind Method; Female; Humans; Infant, Newborn; Kidney Diseases; Male; Pilot Projects; Transposition of Great Vessels | 2010 |
N-acetylcysteine: short-term clinical benefits after coronary angiography in high-risk renal patients.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Double-Blind Method; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Prospective Studies; Risk Factors; Time Factors | 2010 |
Prevention of contrast-induced nephropathy: a single center randomized study.
Topics: Acetylcysteine; Acute Disease; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Incidence; Kidney Diseases; Male; Prospective Studies; Sodium Bicarbonate; Sodium Chloride | 2010 |
Efficacy of N-acetylcysteine and aminophylline in preventing contrast-induced nephropathy.
Topics: Acetylcysteine; Aged; Aminophylline; Angioplasty, Balloon, Coronary; beta 2-Microglobulin; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Kidney Diseases; Male | 2010 |
Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography? A randomized-controlled study.
Topics: Acetylcysteine; Aged; Albuminuria; Angiography; Biomarkers; Contrast Media; Creatinine; Female; Humans; Kidney Diseases; Male; Peripheral Arterial Disease; Retinol-Binding Proteins, Cellular; Statistics, Nonparametric; Treatment Outcome | 2011 |
N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: a randomized trial.
Topics: Acetylcysteine; Contrast Media; Creatinine; Critical Illness; Humans; Kidney Diseases; Radiographic Image Enhancement; Tomography, X-Ray Computed | 2010 |
Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Dose-Response Relationship, Drug; Female; Fluid Therapy; Follow-Up Studies; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2012 |
Intravenous glutathione prevents renal oxidative stress after coronary angiography more effectively than oral N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Aged; Analysis of Variance; Antioxidants; Biomarkers; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Female; Glutathione; Humans; Infusions, Intravenous; Japan; Kidney; Kidney Diseases; Lipid Peroxidation; Lipid Peroxides; Male; Oxidative Stress; Prospective Studies; Time Factors; Treatment Outcome | 2011 |
Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction?
Topics: Acetylcysteine; Administration, Oral; Aged; Angioplasty; Contrast Media; Creatinine; Female; Free Radical Scavengers; Hospital Mortality; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Treatment Outcome | 2011 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Cardiac Catheterization; Catheterization, Peripheral; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Humans; Infusions, Intravenous; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Insufficiency; Risk Assessment; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Time Factors; Treatment Outcome; Vascular Diseases; Wisconsin | 2012 |
A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.
Topics: Acetylcysteine; Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Antioxidants; Biomarkers; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Cystatin C; Double-Blind Method; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; New Orleans; Placebos; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2012 |
Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Chi-Square Distribution; Contrast Media; Cystatin C; Female; Germany; Heart Failure; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Radiography; Recurrence; Risk Assessment; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome; Up-Regulation | 2011 |
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
Does nebivolol prevent contrast-induced nephropathy in humans?
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Antihypertensive Agents; Benzopyrans; Chi-Square Distribution; Contrast Media; Creatinine; Ethanolamines; Female; Free Radical Scavengers; Health Status Indicators; Humans; Kidney Diseases; Male; Middle Aged; Nebivolol; Preoperative Care; Risk Assessment; Statistics as Topic; Vasoconstriction | 2012 |
Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Ioxaglic Acid; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Renal Artery; Treatment Outcome | 2012 |
Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Topics: Acetylcysteine; Adult; Aged; Contrast Media; Coronary Angiography; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Risk Assessment; Single-Blind Method; Sodium Chloride; Theophylline; Treatment Outcome; Vasodilator Agents | 2012 |
N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Contrast Media; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Iohexol; Kidney Diseases; Male; Prospective Studies; Renal Dialysis; Taiwan; Tomography, X-Ray Computed | 2012 |
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Creatinine; Diagnostic Imaging; Enzyme-Linked Immunosorbent Assay; Female; Gelatinases; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Lipocalins; Male; Meglumine; Middle Aged; Organometallic Compounds; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Sodium Bicarbonate; Sodium Chloride | 2013 |
Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Creatinine; Female; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sodium Chloride; Stroke Volume; Treatment Outcome | 2002 |
Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Topics: Acetylcysteine; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Female; Free Radical Scavengers; Humans; Kidney Diseases; Male; Prospective Studies; Statistics as Topic | 2003 |
Did contrast nephropathyin RAPPID really occur?
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Tomography, X-Ray Computed | 2003 |
Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity.
Topics: Acetylcysteine; Aged; Contrast Media; Drug Administration Schedule; Female; Free Radical Scavengers; Humans; Iohexol; Kidney Diseases; Male; Prospective Studies | 2004 |
Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubules; Male; Middle Aged; Oxidative Stress; Risk Factors | 2004 |
Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Humans; Kidney Diseases; Male; Prospective Studies | 2004 |
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Dopamine Agonists; Drug Administration Schedule; Female; Fenoldopam; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Male | 2004 |
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
Topics: Acetylcysteine; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Double-Blind Method; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Treatment Failure | 2004 |
N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabetes Complications; Double-Blind Method; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged | 2004 |
Effectiveness of acetylcysteine in prevention of contrast nephropathy.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Blood Urea Nitrogen; Brazil; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Osmolar Concentration; Prospective Studies; Stroke Volume; Treatment Outcome | 2005 |
N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Female; Humans; Ioxaglic Acid; Kidney Diseases; Male; Middle Aged; Osmolar Concentration | 2005 |
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Topics: Acetylcysteine; Adult; Aged; Cardiac Catheterization; Contrast Media; Female; Fenoldopam; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Prospective Studies | 2006 |
Prophylactic acetylcysteine usage for prevention of contrast nephropathy after coronary angiography.
Topics: Acetylcysteine; Aged; Antioxidants; Blood Urea Nitrogen; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2005 |
Prehydration alone is sufficient to prevent contrast-induced nephropathy after day-only angiography procedures--a randomised controlled trial.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Angiography; Cardiovascular Diseases; Contrast Media; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Fluid Therapy; Free Radical Scavengers; Humans; Infusions, Intravenous; Iohexol; Kidney Diseases; Kidney Function Tests; Male; Middle Aged | 2005 |
Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Drug Administration Schedule; Female; Humans; Incidence; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Sodium Chloride; Treatment Failure | 2006 |
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Contrast Media; Creatinine; Critical Care; Drug Combinations; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Iopamidol; Kidney Diseases; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Risk Factors; Theophylline; Time Factors | 2006 |
N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Creatinine; Female; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction | 2006 |
Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Prospective Studies; Protective Agents | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Diseases; Male; Renal Insufficiency; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome; Triiodobenzoic Acids | 2007 |
Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sodium Bicarbonate; Sodium Chloride | 2007 |
Prevention of contrast-induced nephropathy in vascular surgery patients.
Topics: Acetylcysteine; Ambulatory Care; Aneurysm; Angiography; Contrast Media; Creatinine; Female; Fluid Therapy; Follow-Up Studies; Free Radical Scavengers; Hospitalization; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Peripheral Vascular Diseases; Placebos; Prospective Studies; Risk Factors; Vascular Surgical Procedures | 2007 |
N-Acetylcysteine does not artifactually lower plasma creatinine concentration.
Topics: Acetylcysteine; Aged; Cardiac Surgical Procedures; Contrast Media; Creatinine; Cystatin C; Cystatins; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Intraoperative Care; Kidney Diseases; Male; Middle Aged; Urea | 2008 |
136 other study(ies) available for acetylcysteine and Kidney Diseases
| Article | Year |
|---|---|
Acetaminophen-Induced Nephrotoxicity: Suppression of Apoptosis and Endoplasmic Reticulum Stress Using Boric Acid.
Topics: Acetaminophen; Acetylcysteine; Animals; Apoptosis; Boron; Endoplasmic Reticulum Stress; Kidney Diseases; Rats | 2023 |
Cadmium induces the expression of Interleukin-6 through Heme Oxygenase-1 in HK-2 cells and Sprague-Dawley rats.
Topics: Acetylcysteine; Animals; Antioxidants; Cadmium Chloride; Carbazoles; Cell Line; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Interleukin-6; Kidney Diseases; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2022 |
Protective Effect of N-Acetylcysteine Against Aluminum-Induced Kidney Tissue Damage in Rats.
Topics: Acetylcysteine; Aluminum; Animals; Kidney; Kidney Diseases; Oxidative Stress; Rats; Rats, Wistar; Renal Insufficiency | 2023 |
Solvation Plays a Key Role in Antioxidant-Mediated Attenuation of Elevated Creatinine Level: An In Vitro Spectroscopic Investigation.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Creatinine; Humans; Kidney Diseases; Spectroscopy, Fourier Transform Infrared | 2023 |
Bisphenol A aggravates renal ischemia-reperfusion injury by disrupting mitochondrial homeostasis and N-acetylcysteine mitigates the injurious outcomes.
Topics: Acetylcysteine; Animals; Benzhydryl Compounds; Homeostasis; Kidney; Kidney Diseases; Male; Mitochondria; Oxidative Stress; Phenols; Rats, Wistar; Reperfusion Injury; Sirtuins | 2020 |
Sildenafil and tadalafil reduce the risk of contrast-induced nephropathy by modulating the oxidant/antioxidant balance in a murine model.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Contrast Media; Disease Models, Animal; Glutathione; Kidney Diseases; Male; Mice; Oxidants; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Sildenafil Citrate; Tadalafil; Thiobarbituric Acid Reactive Substances | 2020 |
Evaluation of selected protein biomarkers of renal function in rats with an experimental model of acute cyclophosphamide-induced cystitis treated with N-acetylcysteine.
Topics: Acetylcysteine; Animals; Biomarkers; Cyclophosphamide; Cystitis; Disease Models, Animal; Female; Glomerular Filtration Rate; Kidney Diseases; Kidney Tubules; Male; Rats; Rats, Wistar; Urinary Bladder | 2019 |
Effect of N-Acetyl Cysteine on Renal Interstitial Fibrosis in Mice.
Topics: Acetylcysteine; Animals; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Reactive Oxygen Species; Ureteral Obstruction | 2020 |
A Mechanistic-Based and Non-invasive Approach to Quantify the Capability of Kidney to Detoxify Cysteine-Disulfides.
Topics: Acetylcysteine; Animals; Cysteine; Disulfides; Kidney; Kidney Diseases; Mice; Rats | 2021 |
Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats.
Topics: Acetylcysteine; Animals; Benzhydryl Compounds; Glucosides; Hesperidin; Inflammation; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Protective Agents; Rats; Signal Transduction | 2021 |
Synergistic protective effect of
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cisplatin; Kidney Diseases; Kidney Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Taurine | 2017 |
The Nephroprotective Effect of N-Acetyl-L-Cysteine and Atorvastatin against Imipenem induced Nephrotoxicity.
Topics: Acetylcysteine; Animals; Antioxidants; Atorvastatin; Blood Urea Nitrogen; Creatinine; Glomerular Filtration Rate; Glycosuria; Imipenem; Kidney; Kidney Diseases; Male; Protective Agents; Proteinuria; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Urea | 2018 |
N-Acetylcysteine and Contrast-Induced Nephropathy.
Topics: Acetylcysteine; Blood Platelets; Humans; Kidney Diseases; Lymphocytes; Myocardial Infarction; Percutaneous Coronary Intervention | 2018 |
Response to the Letter to the Editor "N-Acetylcysteine and Contrast-Induced Nephropathy".
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases | 2018 |
N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy.
Topics: Acetylcysteine; Animals; Cardio-Renal Syndrome; Cardiomyopathy, Dilated; Disease Models, Animal; Fibrosis; Glomerular Filtration Rate; Glutathione; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Transgenic; Myocardium; Nephritis; Oxidative Stress; Urinary Tract | 2017 |
N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line; Cell Survival; Cisplatin; Free Radical Scavengers; Humans; Jurkat Cells; Kidney Diseases; Lipid Peroxidation; Male; Necrosis; Rats; Rats, Wistar | 2018 |
Angiography with Sodium Bicarbonate and Acetylcysteine.
Topics: Acetylcysteine; Angiography; Contrast Media; Coronary Angiography; Humans; Kidney Diseases; Sodium Bicarbonate; Sodium Chloride | 2018 |
An experimental study on the preventive effects of N-acetyl cysteine and ozone treatment against contrast-induced nephropathy.
Topics: Acetylcysteine; Animals; Antioxidants; Contrast Media; Creatinine; Ioxaglic Acid; Kidney; Kidney Diseases; Lipocalin-2; Male; Oxidative Stress; Ozone; Protein Carbonylation; Random Allocation; Rats, Wistar; Reference Values; Reproducibility of Results; Spectrophotometry; Treatment Outcome; Urea | 2018 |
Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study.
Topics: Acetylcysteine; Animals; Contrast Media; Disease Models, Animal; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Diseases; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Sildenafil Citrate | 2018 |
Activation of Sirtuin 3 and Maintenance of Mitochondrial Integrity by
Topics: Acetylcysteine; Animals; Apoptosis; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; Kidney Diseases; Male; Mitochondria; Mitochondrial Dynamics; Oxidative Stress; Phenols; Rats; Rats, Wistar; Signal Transduction; Sirtuins; Superoxide Dismutase | 2019 |
N-Acetylcysteine Ameliorates Gentamicin-Induced Nephrotoxicity by Enhancing Autophagy and Reducing Oxidative Damage in Miniature Pigs.
Topics: Acetylcysteine; Animals; Autophagy; Gene Expression Regulation; Gentamicins; Kidney; Kidney Diseases; Oxidation-Reduction; Swine; Swine, Miniature | 2019 |
Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury
Topics: Acetylcysteine; Animals; Blood Urea Nitrogen; Creatinine; Cytokines; Disease Models, Animal; Erythropoietin; Ischemic Preconditioning; Kidney; Kidney Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury | 2019 |
[Contrast-induced nephropathy].
Topics: Acetylcysteine; Combined Modality Therapy; Contrast Media; Creatinine; Fluid Therapy; Free Radical Scavengers; Guideline Adherence; Humans; Kidney Diseases; Renal Dialysis; Risk Factors | 2013 |
Skin rash after oral N-acetylcysteine for kidney protection.
Topics: Acetylcysteine; Administration, Oral; Aged, 80 and over; Exanthema; Female; Free Radical Scavengers; Humans; Kidney Diseases | 2014 |
Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Topics: Acetylcysteine; Adult; Aged; Contrast Media; Creatinine; Critical Illness; Cystatin C; Female; Free Radical Scavengers; Humans; Iohexol; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2013 |
Influence of N-acetylcysteine on Klotho expression and its signaling pathway in experimental model of chronic cyclosporine nephropathy in mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Animals; Antioxidants; Apoptosis; Chronic Disease; Cyclosporine; Deoxyguanosine; Disease Models, Animal; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression; Glucuronidase; Immunosuppressive Agents; Kidney Diseases; Klotho Proteins; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Proto-Oncogene Proteins c-akt; Signal Transduction; Superoxide Dismutase | 2013 |
N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide.
Topics: Acetylcysteine; Animals; Antidotes; Antineoplastic Agents, Alkylating; Antioxidants; Child; Drug Administration Schedule; Humans; Ifosfamide; Kidney Diseases; Neoplasms; Quality of Life | 2013 |
Contributions of endoplasmic reticulum stress and reactive oxygen species to renal injury in aldosterone/salt-induced rats.
Topics: Acetylcysteine; Activating Transcription Factor 4; Aldosterone; Animals; Blotting, Western; Endoplasmic Reticulum Stress; Free Radical Scavengers; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Immunohistochemistry; Kidney; Kidney Diseases; Male; Membrane Proteins; NADPH Oxidases; Phosphoproteins; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium Chloride; Transcription Factor CHOP | 2014 |
GSPE is superior to NAC in the prevention of contrast-induced nephropathy: might this superiority be related to caspase 1 and calpain 1?
Topics: Acetylcysteine; Animals; Calpain; Caspase 1; Contrast Media; Grape Seed Extract; Kidney Diseases; Male; Proanthocyanidins; Rats; Rats, Sprague-Dawley | 2014 |
Impact of N-Acetylcysteine on cerebral amyloid-β plaques and kidney damage in spontaneously hypertensive stroke-prone rats.
Topics: Acetylcysteine; Amyloid beta-Peptides; Analysis of Variance; Animals; Blood-Brain Barrier; Cerebral Cortex; Cerebral Small Vessel Diseases; Disease Models, Animal; Fibronectins; Free Radical Scavengers; Kidney Diseases; Lectins; Male; Plaque, Amyloid; Platelet Membrane Glycoproteins; Rats; Rats, Inbred SHR | 2014 |
Do Montelukast Sodium and N-Acetylcysteine Have a Nephroprotective Effect on Unilateral Ureteral Obstruction? A Placebo Controlled Trial in a Rat Model.
Topics: Acetates; Acetylcysteine; Animals; Cyclopropanes; Disease Models, Animal; Kidney Diseases; Male; Placebos; Quinolines; Randomized Controlled Trials as Topic; Rats; Rats, Wistar; Sulfides; Ureteral Obstruction | 2015 |
Protective effect of salidroside on contrast-induced nephropathy in comparison with N-acetylcysteine and its underlying mechanism.
Topics: Acetylcysteine; Animals; Contrast Media; Cytoprotection; Glucosides; Kidney; Kidney Diseases; Oxidative Stress; Phenols; Rats; Rats, Wistar; Signal Transduction | 2015 |
Carbosulfan-induced oxidative damage following subchronic exposure and the protective effects of N-acetylcysteine in rats.
Topics: Acetylcysteine; Animals; Carbamates; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Synergism; Kidney Diseases; Oxidative Stress; Pesticides; Rats; Rats, Wistar; Reactive Oxygen Species; Treatment Outcome | 2015 |
Renal Protective Effect of Probucol in Rats with Contrast-Induced Nephropathy and its Underlying Mechanism.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Animals; Antioxidants; Contrast Media; Creatinine; Deoxyguanosine; Disease Models, Animal; Immunohistochemistry; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitrogen; Oxidative Stress; Probucol; Rats; Rats, Wistar; Superoxide Dismutase | 2015 |
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney.
Topics: Acetylcysteine; Animals; Atorvastatin; Catalase; Female; Free Radical Scavengers; Glutathione Peroxidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Oxidation-Reduction; Oxidative Stress; Peroxidase; Rats; Reperfusion Injury; Superoxide Dismutase | 2015 |
Improving Intravenous Fluid Therapy for Prevention of Contrast-Induced Nephropathy: How to Give More Without Causing Heart Failure.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Creatinine; Fluid Therapy; Heart Failure; Humans; Kidney Diseases | 2016 |
The effects of N-acetyl-L-cysteine on the female reproductive performance and nephrotoxicity in rats.
Topics: Acetylcysteine; Animals; Female; Kidney; Kidney Diseases; Rats; Rats, Wistar; Reproduction | 2016 |
Paracetamol-induced nephrotoxicity and oxidative stress in rats: the protective role of Nigella sativa.
Topics: Acetaminophen; Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Creatinine; Cytoprotection; Disease Models, Animal; Ethanol; Female; Glutathione; Kidney; Kidney Diseases; Malondialdehyde; Nigella sativa; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats, Wistar; Seeds; Solvents; Superoxide Dismutase; Urea | 2016 |
An Effective and Safe Hydration Method for the Prevention of Contrast-Induced Nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Fluid Therapy; Humans; Kidney Diseases | 2016 |
N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Cell Line; Fibroblasts; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Ureteral Obstruction | 2016 |
Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage.
Topics: Acetylcysteine; Actins; Albuminuria; Animals; Antioxidants; Apoptosis; Gene Expression; Glomerular Filtration Rate; Kidney Diseases; Lipase; Lipid Metabolism; Lipolysis; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Podocytes; Reactive Oxygen Species; RNA, Small Interfering | 2017 |
Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase.
Topics: Acetylcysteine; Aminoquinolines; Animals; Antioxidants; Buthionine Sulfoximine; Disease Models, Animal; Humans; Imiquimod; Inflammation; Kidney; Kidney Diseases; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type II; Oxidative Stress; Psoriasis | 2017 |
Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
Topics: Acetylcysteine; Aged; Angiography; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Sodium Bicarbonate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2008 |
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases | 2008 |
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?
Topics: Acetylcysteine; Contrast Media; Data Interpretation, Statistical; Humans; Kidney Diseases | 2008 |
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?
Topics: Acetylcysteine; Contrast Media; Data Interpretation, Statistical; Humans; Kidney Diseases | 2008 |
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?
Topics: Acetylcysteine; Contrast Media; Data Interpretation, Statistical; Humans; Kidney Diseases | 2008 |
Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty.
Topics: Acetylcysteine; Aged; Angioplasty; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies | 2008 |
N-acetylcysteine-enhanced contrast provides cardiorenal protection.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Animals; Apoptosis; Contrast Media; Creatinine; Disease Models, Animal; Feasibility Studies; Free Radical Scavengers; Iopamidol; Kidney; Kidney Diseases; Myocardial Infarction; Myocardium; Risk Factors; Swine | 2009 |
Contrast loaded with N-acetylcysteine for coronary imaging during percutaneous coronary intervention: a new concept for renal and myocardial protection during percutaneous coronary intervention.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Animals; Apoptosis; Contrast Media; Disease Models, Animal; Free Radical Scavengers; Iopamidol; Kidney; Kidney Diseases; Myocardial Infarction; Myocardium | 2009 |
N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Topics: Acetylcysteine; Aged; Buffers; Coronary Angiography; Creatinine; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Male; Plasma Substitutes; Retrospective Studies; Risk Factors; Sodium Bicarbonate; Triiodobenzoic Acids | 2009 |
N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cisplatin; Kidney; Kidney Diseases; Rats; Rats, Wistar; Renal Circulation; Treatment Outcome | 2010 |
Protective effect of N-acetylcysteine on experimental chronic cadmium nephrotoxicity in immature female rats.
Topics: Acetylcysteine; Animals; Biomarkers; Body Weight; Cadmium; Enzymes; Female; Free Radical Scavengers; Kidney Cortex; Kidney Diseases; Lipid Peroxidation; Oxidative Stress; Protective Agents; Proteinuria; Rats; Rats, Sprague-Dawley; Trace Elements; Urodynamics | 2009 |
Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice.
Topics: Acetylcysteine; Animals; Catalase; Creatinine; Disease Models, Animal; Heat-Shock Proteins; Ischemic Preconditioning; Kidney; Kidney Diseases; Male; Metalloporphyrins; Mice; Mice, Inbred C57BL; Molecular Chaperones; Neoplasm Proteins; Nitric Oxide Synthase Type II; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase; Superoxides | 2010 |
Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine.
Topics: Acetaminophen; Acetylcysteine; Animals; Biomarkers; Catalase; Curcumin; Drug Synergism; Glutathione Peroxidase; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Serologic Tests | 2010 |
In search of an algorithm to prevent acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Algorithms; Clinical Protocols; Contrast Media; Drug Therapy, Combination; Evidence-Based Medicine; Free Radical Scavengers; Humans; Kidney Diseases; Practice Guidelines as Topic; Risk Assessment; Sodium Bicarbonate; Treatment Outcome | 2009 |
Attenuation of gentamicin-induced nephrotoxicity: trimetazidine versus N-acetyl cysteine.
Topics: Acetylcysteine; Acetylglucosaminidase; Animals; Biomarkers; Creatinine; Free Radical Scavengers; gamma-Glutamyltransferase; Gentamicins; Kidney Cortex; Kidney Diseases; Male; Nephrons; Rats; Rats, Wistar; Trimetazidine | 2010 |
N-acetylcysteine in preventing contrast-induced nephropathy. To give, or not to give: that is the question.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases | 2010 |
Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Topics: Acetylcysteine; Aged; Chronic Disease; Cohort Studies; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Prognosis; Quality Assurance, Health Care; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Risk Factors; Sodium Chloride; Tomography, X-Ray Computed | 2010 |
Protective effect of N-acetylcysteine on experimental chronic lead nephrotoxicity in immature female rats.
Topics: Acetylcysteine; Analysis of Variance; Animals; Antioxidants; Female; Free Radical Scavengers; Glutathione; Kidney Cortex; Kidney Diseases; Lead Poisoning; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Single-Blind Method | 2010 |
Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Creatinine; Cystatin C; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 2010 |
Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Risk Factors; Sodium Chloride | 2010 |
[Can the nephroprotective effect of N-acetylcysteine be optimized?].
Topics: Acetylcysteine; Contrast Media; Drug Synergism; Humans; Kidney Diseases | 2010 |
Inhibition of mitochondrial respiratory chain in the brain of rats after renal ischemia is prevented by N-acetylcysteine and deferoxamine.
Topics: Acetylcysteine; Animals; Cell Respiration; Deferoxamine; Disease Models, Animal; Drug Combinations; Drug Synergism; Electron Transport; Electron Transport Complex I; Free Radical Scavengers; Ischemia; Kidney Diseases; Male; Rats; Rats, Wistar | 2010 |
N-acetylcysteine attenuates iodine contrast agent-induced nephropathy in 5/6-nephrectomized rats.
Topics: Acetylcysteine; Animals; Contrast Media; Iodine; Iohexol; Iothalamate Meglumine; Kidney Diseases; Nephrectomy; Premedication; Rats | 2010 |
Contrast-induced nephrotoxicity: possible synergistic effect of stress hyperglycemia.
Topics: Acetylcysteine; Analysis of Variance; Animals; Apoptosis; Contrast Media; Dogs; Hyperglycemia; Kidney Diseases; Kidney Tubules; Necrosis; Osmolar Concentration; Oxidative Stress; Taurine | 2010 |
Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions.
Topics: Acetylcysteine; Analysis of Variance; Angioplasty, Balloon, Coronary; Confidence Intervals; Contrast Media; Emergency Medical Services; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Incidence; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Severity of Illness Index; Singapore; Sodium Chloride; Stroke Volume; Ventricular Function, Left | 2010 |
Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Colistin; Female; Kidney Diseases; Lung; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2011 |
N-acetylcysteine somewhere between Scylla and Charybdis.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Myocardial Infarction; Randomized Controlled Trials as Topic; Reperfusion Injury | 2010 |
Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
Topics: Acetylcysteine; Actins; Animals; Cells, Cultured; Cysteine Proteinase Inhibitors; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibroblasts; Fibrosis; Kidney Diseases; Leupeptins; Male; Nerve Tissue Proteins; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Smad Proteins, Receptor-Regulated; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta; Ureteral Obstruction | 2011 |
Effects of N-acetylcysteine on renal hemodynamics in contrast media-induced nephropathy.
Topics: Acetylcysteine; Animals; Contrast Media; Hemodynamics; Kidney; Kidney Diseases; Rats; Rats, Sprague-Dawley; Renal Circulation | 2011 |
Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Arginine; Belgium; Biomarkers; Case-Control Studies; Cell Line; Chronic Disease; Cross-Sectional Studies; Female; Humans; Inflammation Mediators; Interleukin-6; Kidney Diseases; Linear Models; Male; Middle Aged; Monocytes; NF-kappa B; Predictive Value of Tests; ROC Curve; Tumor Necrosis Factor-alpha | 2011 |
N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C.
Topics: Acetylcysteine; Aged; Contrast Media; Cystatin C; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged | 2013 |
NAC and CIN prevention: mounting evidence of inefficacy.
Topics: Acetylcysteine; Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Antioxidants; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male | 2012 |
[ Use of N-acetylcysteine for the prevention of contrast-induced nephropathy in rats].
Topics: Acetylcysteine; Animals; Antioxidants; Arterioles; Contrast Media; Drug Evaluation, Preclinical; Iopamidol; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Nephritis, Interstitial; Random Allocation; Rats; Rats, Wistar; Single-Blind Method; Water Deprivation | 2012 |
[Therapeutic effect of acetylcysteine on rats with gentamicin-induced nephropathy].
Topics: Acetylcysteine; Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Creatinine; Female; Gentamicins; Kidney Diseases; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Proteinuria; Rats | 2012 |
Chronic cyclosporine nephropathy is characterized by excessive autophagosome formation and decreased autophagic clearance.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Animals; Antioxidants; Apoptosis; Autophagy; Caspase 3; Cyclosporine; Deoxyguanosine; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Kidney Diseases; Male; Mice; Microscopy, Electron; Microtubule-Associated Proteins; Oxidative Stress; Phagosomes; Pravastatin; Time Factors | 2012 |
An iTRAQ-based mitoproteomics approach for profiling the nephrotoxicity mechanisms of ochratoxin A in HEK 293 cells.
Topics: Acetylcysteine; Calcium Channel Blockers; Electron Transport Chain Complex Proteins; Free Radical Scavengers; HEK293 Cells; Humans; Kidney Diseases; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Proteins; Models, Biological; Ochratoxins | 2013 |
Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study.
Topics: Acetylcysteine; Aged; Contrast Media; Female; Fluid Therapy; Hospital Mortality; Humans; Italy; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Prospective Studies; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome | 2012 |
Characterization of the chemical reactivity and nephrotoxicity of N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine sulfoxide, a potential reactive metabolite of trichloroethylene.
Topics: Acetylcysteine; Animals; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Trichloroethylene | 2013 |
The third strike.
Topics: Acetylcysteine; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Radiopharmaceuticals; Sodium Chloride | 2002 |
N-acetylcysteine ameliorates renal microcirculation: studies in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Dinoprostone; Enzyme Inhibitors; Hypoxia; Kidney Cortex; Kidney Diseases; Kidney Medulla; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation | 2003 |
Should intravenous N-acetylcysteine be considered standard of care for prevention of radio-contrast-induced nephropathy?
Topics: Acetylcysteine; Contrast Media; Humans; Injections, Intravenous; Kidney Diseases; Randomized Controlled Trials as Topic | 2003 |
Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
Topics: Acetylcysteine; Contrast Media; Drug Interactions; Free Radical Scavengers; Humans; Kidney Diseases | 2004 |
Contrast agent nephropathy.
Topics: Acetylcysteine; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases | 2004 |
Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Confounding Factors, Epidemiologic; Contrast Media; Female; Hospitalization; Humans; Incidence; Kidney Diseases; Male; Middle Aged | 2004 |
Investigating the volume status before contrast nephropathy studies.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Kidney Tubules; Oxidative Stress | 2005 |
N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration.
Topics: Acetylcysteine; Administration, Oral; Clinical Trials as Topic; Contrast Media; Humans; Infusions, Intravenous; Kidney Diseases | 2005 |
Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Free Radical Scavengers; Kidney Diseases; Kidney Tubules; Lipid Peroxidation; Male; Oxidation-Reduction; Oxidative Stress; Proteins; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thioglycolates; Thiophenes | 2006 |
Contrast-induced nephropathy: pharmacological prophylaxis.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Ascorbic Acid; Calcium Channel Blockers; Contrast Media; Dopamine; Humans; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic; Vasoconstriction | 2006 |
Preventing nephropathy induced by contrast medium.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Risk | 2006 |
Interactions between serum creatinine, volume status, N-acetylcysteine, and contrast-induced nephropathy.
Topics: Acetylcysteine; Blood Volume; Contrast Media; Creatinine; Humans; Kidney Diseases | 2006 |
The effects of N-acetylcysteine on methotrexate-induced oxidative renal damage in rats.
Topics: Acetylcysteine; Animals; Antioxidants; Glutathione; Humans; Kidney; Kidney Diseases; Methotrexate; Oxidants; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar | 2007 |
Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Free Radical Scavengers; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Protective Agents; Retrospective Studies | 2006 |
N-acetylcysteine and contrast-induced nephropathy.
Topics: Acetylcysteine; Contrast Media; Creatinine; Humans; Kidney Diseases | 2006 |
N-acetylcysteine and contrast-induced nephropathy.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Creatinine; Cystatin C; Cystatins; Glomerular Filtration Rate; Humans; Kidney Diseases; Myocardial Infarction | 2006 |
N-acetylcysteine and contrast-induced nephropathy.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Hospitals, Teaching; Humans; Kidney Diseases; Myocardial Infarction; Renal Replacement Therapy | 2006 |
N-acetylcysteine and contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Contrast Media; Dose-Response Relationship, Drug; Hospital Mortality; Humans; Kidney Diseases; Myocardial Infarction | 2006 |
N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
Topics: Acetylcysteine; Animals; Blood Pressure; Disease Models, Animal; Free Radical Scavengers; Glomerular Filtration Rate; Glutathione; Hypertension; Kidney Diseases; Male; Oxidative Stress; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary | 2006 |
Are 4-hydroxy-2(E)-nonenal derived mercapturic acids and (1)H NMR metabonomics potential biomarkers of chemically induced oxidative stress in the kidney?
Topics: Acetylcysteine; Alanine Transaminase; Aldehydes; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bromates; Creatinine; gamma-Glutamyltransferase; Histocytochemistry; Kidney Diseases; Magnetic Resonance Spectroscopy; Male; Nitrilotriacetic Acid; Oxidative Stress; Principal Component Analysis; Rats; Thiobarbituric Acid Reactive Substances; Urea | 2007 |
N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sodium Bicarbonate | 2007 |
Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Urea Nitrogen; Caffeic Acids; Catalase; Disease Models, Animal; Drinking; Drug Combinations; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Kidney Diseases; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Vancomycin; Vitamin E; Water Supply | 2007 |
Preventing contrast nephropathy in catheter laboratory.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Contrast Media; Coronary Angiography; Hemofiltration; Humans; Kidney; Kidney Diseases; Trimetazidine; Vasodilator Agents | 2007 |
Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aging; Child; Chronic Disease; Contrast Media; Drug Interactions; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Kidney Diseases; Metformin; Renal Dialysis; Risk Assessment | 2007 |
Role of focal adhesion kinase (FAK) in renal ischaemia and reperfusion.
Topics: Acetylcysteine; Adenosine Triphosphate; Animals; Cell Line; Cells, Cultured; Dogs; Focal Adhesion Protein-Tyrosine Kinases; Free Radical Scavengers; Kidney; Kidney Diseases; Loop of Henle; Male; Phosphorylation; Rats; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction | 2007 |
Prevention of contrast-induced nephropathy in high-risk patients with hemofiltration.
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Hemofiltration; Humans; Kidney Diseases; Research Design; Triiodobenzoic Acids; Urine | 2007 |
[Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Topics: Acetylcysteine; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Critical Pathways; Female; Humans; Kidney Diseases; Male; Middle Aged; Osmolar Concentration; Renal Insufficiency, Chronic; Sodium Bicarbonate | 2007 |
Effect of N-acetylcysteine on renal function in patients with chronic kidney disease.
Topics: Acetylcysteine; Aged; Chronic Disease; Cimetidine; Creatinine; Cystatin C; Cystatins; Drug Synergism; Female; Free Radical Scavengers; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Time Factors | 2007 |
Formation of three N-acetyl-L-cysteine monoadducts and one diadduct by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with N-acetyl-L-cysteine at physiological conditions: chemical mechanisms and toxicological implications.
Topics: Acetylcysteine; Cross-Linking Reagents; Cysteine; Free Radical Scavengers; Kidney; Kidney Diseases; Sulfoxides | 2007 |
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.
Topics: Acetylcysteine; Administration, Oral; Animals; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Free Radical Scavengers; Injections, Intra-Arterial; Injections, Intraperitoneal; Injections, Intravenous; Kidney Diseases; Kidney Function Tests; Rats; Rats, Long-Evans | 2008 |
N-acetylcysteine and/or theophylline as a preventive measure for contrast agent induced nephropathy: we should use better markers for detection of renal function.
Topics: Acetylcysteine; Biomarkers; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Phosphodiesterase Inhibitors; Theophylline | 2007 |
Influence of N-acetylcysteine on renal toxicity of cadmium in rats.
Topics: Acetylcysteine; Animals; Cadmium Chloride; Catalase; Chemoprevention; Creatine; Disease Models, Animal; Drug Antagonism; Free Radical Scavengers; Glomerular Filtration Rate; Glutathione; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Urea | 2008 |
Contrast-induced nephropathy and mortality: possible crucial role of asymmetric dimethylarginine.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Antioxidants; Arginine; Biomarkers; Contrast Media; Coronary Angiography; Humans; Kidney Diseases; Nitric Oxide | 2007 |
N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats.
Topics: Acetylcysteine; Animals; Antineoplastic Agents, Alkylating; beta 2-Microglobulin; Creatinine; Disease Models, Animal; Free Radical Scavengers; Glutathione; Glutathione Transferase; Ifosfamide; Kidney Diseases; Lipid Peroxides; Magnesium; Male; Rats; Rats, Wistar; Severity of Illness Index | 2008 |
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Humans; Iopamidol; Kidney Diseases; Randomized Controlled Trials as Topic; Research Design; Sampling Studies; Sodium Bicarbonate; Triiodobenzoic Acids | 2008 |
Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Brain Diseases, Metabolic; Creatine Kinase; Deferoxamine; Down-Regulation; Ischemia; Kidney Diseases; Male; Nerve Degeneration; Oxidative Stress; Rats; Rats, Wistar; Subcellular Fractions; Time Factors; Treatment Outcome; Uremia | 2008 |
Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Drug Therapy, Combination; Humans; Kidney Diseases; Sodium Bicarbonate; Sodium Chloride | 2008 |
N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.
Topics: Acetylcysteine; Animals; Aquaporin 2; Glomerular Filtration Rate; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nitric Oxide Synthase Type III; Osmolar Concentration; Rats; Rats, Wistar; Renal Circulation; Thiobarbituric Acid Reactive Substances; Ureteral Obstruction; Urine | 2008 |
Effects of N-acetylcysteine on angiotensin-converting enzyme plasma activity in patients with chronic kidney diseases.
Topics: Acetylcysteine; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Peptidyl-Dipeptidase A; Proteinuria; Randomized Controlled Trials as Topic | 2008 |
The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Fluid Therapy; Humans; Kidney Diseases | 2009 |
Prophylaxis of ifosfamide toxicity with oral acetylcysteine.
Topics: Acetylcysteine; Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematuria; Humans; Ifosfamide; Kidney Diseases; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 1983 |
Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Topics: Acetylcysteine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Ditiocarb; Kidney Diseases; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mutagens; Neoplasm Transplantation; Urea | 1994 |
Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Aldehydes; Animals; Antioxidants; Carcinogens; Deoxyguanosine; DNA; DNA Damage; Ferric Compounds; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Lipid Peroxidation; Male; Mesna; Nitrilotriacetic Acid; Oxidative Stress; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 1996 |
The nephrotoxicity and hepatotoxicity of 1,1,2,2-tetrafluoroethyl-L-cysteine in the rat.
Topics: Acetylcysteine; Aminooxyacetic Acid; Animals; Butadienes; Cysteine; Dose-Response Relationship, Drug; Female; Hydrocarbons, Fluorinated; Ion Transport; Kidney Diseases; Male; Probenecid; Rats; Renal Agents | 1998 |
Fate and toxicity of 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived mercapturates in male, Fischer 344 rats.
Topics: Acetylcysteine; Acyltransferases; Anesthetics, Inhalation; Animals; Biotransformation; Chemical and Drug Induced Liver Injury; Cytosol; Dealkylation; Drug Contamination; Ethers; Hydrocarbons, Fluorinated; Kidney Diseases; Magnetic Resonance Spectroscopy; Male; Methyl Ethers; Rats; Rats, Inbred F344; Sevoflurane | 1998 |
Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteine.
Topics: Acetylcysteine; Animals; Cadmium Poisoning; Female; Free Radical Scavengers; Kidney Diseases; L-Lactate Dehydrogenase; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Cytokine gene expression in Adriamycin nephropathy: effects of antioxidant nuclear factor kappaB inhibitors in established disease.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Antioxidants; Cytokines; Doxorubicin; Free Radical Scavengers; Kidney Diseases; Male; NF-kappa B; Nuclear Proteins; Pyrrolidines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiocarbamates | 2000 |
Re: Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention.
Topics: Acetylcysteine; Contrast Media; Humans; Kidney Diseases; Metformin | 2001 |
Efficacy of N-acetylcysteine to reduce the effects of aflatoxin B1 intoxication in broiler chickens.
Topics: Acetylcysteine; Aflatoxin B1; Alanine Transaminase; Animal Feed; Animals; Aspartate Aminotransferases; Blood Proteins; Body Weight; Chemical and Drug Induced Liver Injury; Chickens; Free Radical Scavengers; Glutathione; Glutathione Transferase; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Poultry Diseases; Random Allocation; Treatment Outcome | 2001 |
Effect of three n-acetylamino acids on N-(3,5-dichlorophenyl)succinimide (NDPS) and ndps metabolite nephrotoxicity in Fischer 344 rats.
Topics: Acetylcysteine; Alanine; Amino Acids; Animals; Fungicides, Industrial; Injections, Intraperitoneal; Kidney; Kidney Diseases; Kidney Function Tests; Liver; Male; Rats; Rats, Inbred F344; Serine; Serotonin; Succinates; Succinimides | 2002 |
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
Topics: Acetaminophen; Acetylcysteine; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Cysteamine; Female; Humans; Infusions, Parenteral; Kidney Diseases; Liver Diseases; Male; Methionine; Middle Aged; Risk; Time Factors | 1979 |
Nephrotoxicity of paracetamol in the rat--mechanistic and therapeutic aspects.
Topics: Acetaminophen; Acetylcysteine; Acetylglucosaminidase; Animals; Antidotes; Ditiocarb; gamma-Glutamyltransferase; Kidney Diseases; L-Iditol 2-Dehydrogenase; Male; Rats; Rats, Inbred Strains | 1991 |
Metabolism of L-cysteine S-conjugates and N-(trideuteroacetyl)-L-cysteine S-conjugates of four fluoroethylenes in the rat. Role of balance of deacetylation and acetylation in relation to the nephrotoxicity of mercapturic acids.
Topics: Acetylation; Acetylcysteine; Amidohydrolases; Animals; Arylamine N-Acetyltransferase; Bile; Chlorofluorocarbons; Cysteine; Deuterium; Ethylenes; Gas Chromatography-Mass Spectrometry; Hydrocarbons, Fluorinated; Hydrocarbons, Halogenated; Kidney; Kidney Diseases; Liver; Male; Rats; Rats, Inbred Strains; Subcellular Fractions | 1991 |
Nephrotoxicity of mercapturic acids of three structurally related 2,2-difluoroethylenes in the rat. Indications for different bioactivation mechanisms.
Topics: Acetylcysteine; Animals; Biotransformation; Cysteine; Dose-Response Relationship, Drug; Fluoroacetates; Glycosuria; Hydrocarbons, Fluorinated; Hydrocarbons, Halogenated; Kidney Diseases; Organ Size; Proteinuria; Pyruvates; Pyruvic Acid; Rats; Structure-Activity Relationship; Urea | 1988 |
Differential toxicity as a result of apical and basolateral treatment of LLC-PK1 monolayers with S-(1,2,3,4,4-pentachlorobutadienyl)glutathione and N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine.
Topics: Acetylcysteine; Aminooxyacetic Acid; Animals; Anion Transport Proteins; Anions; Biological Transport; Butadienes; Carrier Proteins; Cations; Cell Line; Cell Survival; Epithelial Cells; Epithelium; Glutathione; Isoxazoles; Kidney; Kidney Diseases; p-Aminohippuric Acid; Swine; Tetraethylammonium; Tetraethylammonium Compounds | 1988 |
Nephrotoxicity of hexachlorobutadiene and its glutathione-derived conjugates.
Topics: Acetylcysteine; Animals; Butadienes; Cysteine; Female; Glutathione; Kidney Diseases; Kidney Medulla; Kidney Tubules, Proximal; Male; Necrosis; Rats; Sex Factors; Urea | 1986 |